A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplantation

Published:2011-09 Issue:9 Volume:17 Page:1308-1315
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Inamoto Yoshihiro,Fefer Alexander,Sandmaier Brenda M.,Gooley Theodore A.,Warren Edus H.,Petersdorf Stephen H.,Sanders Jean E.,Storb Rainer F.,Appelbaum Frederick R.,Martin Paul J.,Flowers Mary E.D.

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

Banyu Life Science Foundation International

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation;Mielcarek;Biol Blood Marrow Transplant,2007

2. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy;Mortimer;J Clin Oncol,1989

3. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens;Radich;J Clin Oncol,1993